Related Experiment Videos
Abstract:
Nine patients with pseudomembranous colitis (PMC) are described. Eight patients received prior therapy with antibiotics. Pyrexia and polymorph leukocytosis were common features. Six relapses occurred in four of the six patients who were treated with vancomycin. Two patients who did not receive vancomycin died.
Insights
Pseudomembranous colitis (PMC) patients treated with vancomycin experienced relapses. Early antibiotic use was common in PMC cases, and patients not receiving vancomycin had fatal outcomes.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Internal Medicine
Background:
- Pseudomembranous colitis (PMC) is a serious intestinal condition often linked to prior antibiotic use.
- Common clinical signs include fever (pyrexia) and elevated white blood cell counts (polymorph leukocytosis).
Purpose of the Study:
- To describe the clinical course and treatment outcomes of patients diagnosed with pseudomembranous colitis.
- To evaluate the efficacy and safety of vancomycin in treating PMC.
Main Methods:
- A case series describing nine patients with confirmed pseudomembranous colitis.
- Review of patient histories, focusing on prior antibiotic exposure and treatment regimens.
Main Results:
- Eight out of nine patients had a history of recent antibiotic therapy.
- Four of six patients treated with vancomycin experienced six relapses.
- Two patients who did not receive vancomycin treatment unfortunately died.
Conclusions:
- Vancomycin treatment for pseudomembranous colitis may be associated with a high rate of relapse.
- Alternative or adjunctive therapies should be considered for PMC management.
- Prompt and effective treatment is critical, as evidenced by the mortality in untreated patients.